Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212] (S1476558616000257)(10.1016/j.neo.2016.02.005)

Chi Wei Chen, Ming Hsi Wu, Yi Fan Chen, Tsai Yi Yen, Yi Wen Lin, Shu Hsin Chao, Satishkumar Tala, Tung Hu Tsai, Tsann Long Su, Te Chang Lee*

*此作品的通信作者

研究成果: Comment/debate

2 引文 斯高帕斯(Scopus)

摘要

The authors regret to have mistakenly placed the figure of body weight change in mice treated with different agents in PC9 cells (Figure 6A, right) with that of PC9/gef B4 cells (Figure 6B, right) during the art work. The corrected Figure 6 was attached below. The authors would like to apologize for any inconvenience caused.

原文English
頁(從 - 到)808-809
頁數2
期刊Neoplasia
18
發行號12
DOIs
出版狀態Published - 2016

指紋

深入研究「Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212] (S1476558616000257)(10.1016/j.neo.2016.02.005)」主題。共同形成了獨特的指紋。

引用此